LLY

1,130.08

+0.44%↑

JNJ

232.65

+1.91%↑

ABBV

227.34

+1.09%↑

UNH

400.31

+0.89%↑

MRK

120.93

+0.57%↑

LLY

1,130.08

+0.44%↑

JNJ

232.65

+1.91%↑

ABBV

227.34

+1.09%↑

UNH

400.31

+0.89%↑

MRK

120.93

+0.57%↑

LLY

1,130.08

+0.44%↑

JNJ

232.65

+1.91%↑

ABBV

227.34

+1.09%↑

UNH

400.31

+0.89%↑

MRK

120.93

+0.57%↑

LLY

1,130.08

+0.44%↑

JNJ

232.65

+1.91%↑

ABBV

227.34

+1.09%↑

UNH

400.31

+0.89%↑

MRK

120.93

+0.57%↑

LLY

1,130.08

+0.44%↑

JNJ

232.65

+1.91%↑

ABBV

227.34

+1.09%↑

UNH

400.31

+0.89%↑

MRK

120.93

+0.57%↑

Home・Aktien・ResMed Inc

ResMed Inc

Geschlossen

BrancheGesundheitswesen

195.63 0.84

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

194.54

Max

196.27

Schlüsselkennzahlen
By Trading Economics
Einkommen	6.1M 399M
Verkäufe	8.6M 1.4B
KGV Branchendurchschnitt	17.979 49.888
EPS	2.86
Dividendenrendite	1.22
Gewinnspanne	27.856
Angestellte	10,600
EBITDA	-67M 500M

Empfehlungen
By TipRanks
Empfehlungen	Buy
12-Monats-Prognose	+37.78% upside

Dividenden
By Dow Jones
Dividendenrendite Branchendurchschnitt	1.22% 2.38%
Nächstes Ergebnis	30. Juli 2026
Nächste Dividendenausschüttung	18. Juni 2026
Nächstes Ex-Dividendendatum	13. Aug. 2026

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	-5.3B 27B
Vorheriger Eröffnungskurs	194.79
Vorheriger Schlusskurs	195.63

Nachrichtenstimmung

By Acuity

34%

66%

76 / 344 Ranking in Healthcare

ResMed Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Peer-Vergleich

Kursveränderung

ResMed Inc Prognose

Kursziel

By TipRanks

37.78% Vorteil

12-Monats-Prognose

Durchschnitt 270.1 USD 37.78%

Hoch 340 USD

Tief 225 USD

Basierend auf 14 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für ResMed Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

14 ratings

Buy

Halten

Sell

Basierend auf 14 Analysten, die in den letzten 3 Monaten Aktienbewertungen für ResMed Inc – Dist abgegeben haben.

Stimmung

By Acuity

76 / 344 Ranking in Gesundheitswesen

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über ResMed Inc

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.